Tunlametinib (HL-085) is an oral, selective, mitogen-activated protein kinase kinase 1 and 2 (MEK 1/2) inhibitor, for…
About Anlotinib Anlotinib is a orally administered tyrosine kinase inhibitor that targets vascular endothelial growth factor…
Entinostat is a synthetic drug that inhibits histone deacetylase (HDAC) enzymes. Entinostat sold as brand name 景助达® …
Surufatinib is a novel, oral angio-immuno kinase inhibitor that selectively inhibits the tyrosine kinase activity associated…
About Iparomlimab/Tuvonralimab A mixture of the two engineered monoclonal antibodies iparomlimab, which is an immunoglobulin G4…
Pamiparib (BGB-290) is a drug used to treat various types of cancer. It's a PARP inhibitor,…
Socazolimab is a fully human anti-PD-L1 (programmed cell death 1 ligand 1) monoclonal antibody, an immune checkpoint…
Enlonstobart, a recombinant, fully humanised immunoglobulin G4 monoclonal antibody targeted against programmed cell death protein 1 (PD-1),…
Olverembatinib is a small-molecule, oral BCR-ABL1 TKI that works by inhibiting the BCR-ABL1 kinase at the…
Chidamide (also named Tucidinostat) is a histone deacetylase (HDAC) inhibitor that is used to treat various…
About Pirtobrutinib Pirtobrutinib is an inhibits B cell lymphocyte proliferation and survival by binding and inhibiting Bruton's tyrosine…
Golidocitinib (DZD4205) is currently the first and only Janus kinase 1 (JAK1) selective inhibitor being evaluated…
Zuberitamab is an innovative anti-CD20 monoclonal antibody injection. Zuberitamab is a biosimilar of rituximab, a monoclonal…
Ripertamab (SCT400) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab sold under the brand name…
Linperlisib, a next-generation PI3Kδ-selective oral inhibitor, received marketing approval in China in 2022 for treatment of…
Orelabrutinib is a novel, highly selective, irreversible BTK inhibitor with high target selectivity and safety. Orelabrutinib sold…
Copyright © 2021-2022 LienTeh.net All rights reserved.
